1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Philippe ROUSSELOT: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Precision Medicine Trial for Patients With Relapsed or Refractory T Cell ALL Venetoclax + Tofacitinib, Venetoclax+ Everoliumus +Enrylaze, Venetoclax + 5 Azacitidine - LAL | Phase 2 | Not yet recruiting | Philippe ROUSSELOT | 93 | 2026-09-01 | 2026-04-17 |
tofacitinib (1) · venetoclax (1)
Czechia (1) · France (1) · Germany (1) · Netherlands (1) · Poland (1) · Spain (1)